首页> 美国政府科技报告 >Evaluation of Immunotherapeutic Approaches for the Potential Treatment of Infections Caused by K1 Positive Escherichia coli.

【24h】

Evaluation of Immunotherapeutic Approaches for the Potential Treatment of Infections Caused by K1 Positive Escherichia coli.

机译：评价K1阳性大肠杆菌感染潜在治疗的免疫治疗方法。

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

No abstract available.

著录项

作者
Cross, A.; Zollinger, W.; Mandrell, R.; Gemski, P.; Sadoff, J.;
展开▼
作者单位

展开▼
年度 1981
页码 1-11
总页数 11
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Immunization; Antibodies; Meningitis; Escherichia coli; Polysaccharides; Serology; Vaccines; Immunoglobulins; Humans; Mice; Reprints;

机译：免疫;抗体;脑膜炎;大肠杆菌;多糖;血清学;疫苗;免疫球蛋白;人类;小鼠;重印;

相似文献

外文文献
中文文献
专利

1. Potential Role of Fosfomycin in the Treatment of Community-Acquired Lower Urinary Tract Infections Caused by Extended-Spectrum [beta]-Lactamase-Producing Escherichia coli. [J] . Wilson Dustin T., May D. Byron American journal of therapeutics . 2013,第6期

机译：磷霉素在治疗产生广谱β-内酰胺酶的大肠杆菌引起的社区获得性下尿路感染中的潜在作用。
2. Novel immunotherapeutic approaches to the treatment of infections caused by Gram-negative bacteria. [J] . Palliyil S, Broadbent ID Current opinion in pharmacology . 2009,第5期

机译：用于治疗革兰氏阴性菌感染的新型免疫疗法。
3. Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. [J] . Auer S, Wojna A, Hell M Antimicrobial agents and chemotherapy. . 2010,第9期

机译：由产生广谱β-内酰胺酶的大肠埃希菌引起的非卧床尿路感染患者的口服治疗选择。
4. Efficacy and Safety of Polymyxin B in the Treatment of Infections Caused by Multidrug- Resistant Gram-Negative Infections: A Retrospective Review [C] . Oh HML, Gan LH, Wee I International Congress of Chemotherapy and Infection . 2009

机译：多种抗革兰阴性感染治疗感染治疗感染的疗效和安全性：回顾性综述
5. The within host population dynamics of acute Escherichia coli K1 infection in mice and its treatment with antibiotics. [D] . Zappala, Renata M. 2004

机译：小鼠中急性大肠杆菌K1感染的宿主内部种群动态及其抗生素治疗。
6. Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli. [O] . W Kern, S L Kennedy, M Sachdeva, 1990

机译：评价哌拉西林-他唑巴坦在生产β-内酰胺酶的K1阳性大肠杆菌引起的实验性脑膜炎中。
7. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli. [O] . Arne Søraas, Arnfinn Sundsfjord, Silje Bakken Jørgensen, 2014

机译：由产EsBL的大肠杆菌引起的社区获得性尿路感染的每口服mecillinam治疗失败率高。
8. Evaluation of Immunotherapeutic Approaches for the Potential Treatment of Infections Caused by K1 Positive Escherichia coli [R] . Cross, A., Zollinger, W., Mandrell, R., 1981

机译：评价K1阳性大肠杆菌感染潜在治疗的免疫治疗方法

Evaluation of Immunotherapeutic Approaches for the Potential Treatment of Infections Caused by K1 Positive Escherichia coli.

摘要

著录项

相似文献

相关主题

期刊订阅